Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 2
1993 2
2003 2
2004 1
2008 2
2009 3
2010 1
2017 1
2018 1
2021 2
2022 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone.
Fattovich G, Zagni I, Ribero ML, Castagnetti E, Minola E, Lomonaco L, Scattolini C, Fabris P, Boccia S, Giusti M, Abbati G, Felder M, Rovere P, Redaelli A, Tonon A, Tomba A, Montanari R, Paternoster C, Distasi M, Fornaciari G, Tositti G, Rizzo C, Suppressa S, Pantalena M, Noventa F, Tagger A. Fattovich G, et al. Among authors: scattolini c. J Viral Hepat. 2004 Nov;11(6):543-51. doi: 10.1111/j.1365-2893.2004.00538.x. J Viral Hepat. 2004. PMID: 15500555 Clinical Trial.
Identification of a novel antibody associated with autoimmune pancreatitis.
Frulloni L, Lunardi C, Simone R, Dolcino M, Scattolini C, Falconi M, Benini L, Vantini I, Corrocher R, Puccetti A. Frulloni L, et al. Among authors: scattolini c. N Engl J Med. 2009 Nov 26;361(22):2135-42. doi: 10.1056/NEJMoa0903068. N Engl J Med. 2009. PMID: 19940298 Free article.
Efficacy of prolonged 5 million units of interferon in combination with ribavirin for relapser patients with chronic hepatitis C.
Fattovich G, Zagni I, Fornaciari G, Minola E, Fabris P, Boccia S, Giusti M, Abbati G, Felder M, Rovere P, Redaelli A, Tonon A, Montanari R, Paternoster C, Distasi M, Castagnetti E, Tositti G, Rizzo C, Suppressa S, Pantalena M, Lomonaco L, Scattolini C, Tagger A. Fattovich G, et al. Among authors: scattolini c. J Viral Hepat. 2003 Mar;10(2):111-7. doi: 10.1046/j.1365-2893.2003.00409.x. J Viral Hepat. 2003. PMID: 12614467 Clinical Trial.
A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C.
Fattovich G, Zagni I, Minola E, Felder M, Rovere P, Carlotto A, Suppressa S, Miracolo A, Paternoster C, Rizzo C, Rossini A, Benedetti P, Capanni M, Ferrara C, Costa P, Bertin T, Pantalena M, Lomonaco L, Scattolini C, Mazzella G, Giusti M, Boccia S, Milani S, Marin R, Lisa Ribero M, Tagger A. Fattovich G, et al. Among authors: scattolini c. J Hepatol. 2003 Nov;39(5):843-9. doi: 10.1016/s0168-8278(03)00391-x. J Hepatol. 2003. PMID: 14568269 Clinical Trial.
Emergently planned exclusive hub-and-spoke system in the epicenter of the first wave of COVID-19 pandemic in Italy: the experience of the largest COVID-19-free ICU hub for time-dependent diseases.
Chieregato A, Veronese G, Curto F, Zaniboni M, Fossi F, Zumbo F, Scattolini C, Compagnone C, Alberti BM, Baciu C, Bergesio L, Carenini SM, Chevallard G, Cipolla C, Formentano AC, Guidi A, Massimo F, Galluccio I, Pagani S, Paparone R, Pozzi F, Pressato L, Pugnetti E, Riganti M, Ruggieri F, Tagliaferri F, Trinchero G, Vassena E, Bassi G, Giudici R, Sacchi M, Chiara O, Agostoni EC, Grasselli G, Fumagalli R. Chieregato A, et al. Among authors: scattolini c. Minerva Anestesiol. 2021 Oct;87(10):1091-1099. doi: 10.23736/S0375-9393.21.15455-0. Epub 2021 Jun 8. Minerva Anestesiol. 2021. PMID: 34102806 Free article.
18 results